Bowman & Co S.C. Buys 83 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Bowman & Co S.C. raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.3% in the 2nd quarter, Holdings Channel reports. The firm owned 1,645 shares of the healthcare conglomerate’s stock after acquiring an additional 83 shares during the period. Bowman & Co S.C.’s holdings in UnitedHealth Group were worth $841,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Signature Resources Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 18 shares during the last quarter. Continuum Advisory LLC boosted its holdings in shares of UnitedHealth Group by 0.6% during the 2nd quarter. Continuum Advisory LLC now owns 3,410 shares of the healthcare conglomerate’s stock valued at $1,737,000 after purchasing an additional 19 shares during the last quarter. Veracity Capital LLC boosted its holdings in shares of UnitedHealth Group by 1.5% during the 1st quarter. Veracity Capital LLC now owns 1,335 shares of the healthcare conglomerate’s stock valued at $660,000 after purchasing an additional 20 shares during the last quarter. Rodgers Brothers Inc. boosted its holdings in shares of UnitedHealth Group by 2.4% during the 1st quarter. Rodgers Brothers Inc. now owns 842 shares of the healthcare conglomerate’s stock valued at $417,000 after purchasing an additional 20 shares during the last quarter. Finally, Aprio Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 2.1% in the 2nd quarter. Aprio Wealth Management LLC now owns 975 shares of the healthcare conglomerate’s stock valued at $497,000 after acquiring an additional 20 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Up 1.0 %

Shares of NYSE:UNH traded up $5.79 during trading on Friday, reaching $584.51. 2,222,692 shares of the company were exchanged, compared to its average volume of 4,165,972. The firm has a market capitalization of $539.75 billion, a PE ratio of 35.73, a P/E/G ratio of 1.61 and a beta of 0.59. The business’s fifty day simple moving average is $537.83 and its 200-day simple moving average is $509.96. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $591.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. UnitedHealth Group’s revenue was up 6.4% compared to the same quarter last year. During the same period last year, the company posted $6.14 earnings per share. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.44%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s payout ratio is 51.34%.

Analysts Set New Price Targets

A number of brokerages recently commented on UNH. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and increased their price target for the company from $481.00 to $647.00 in a report on Wednesday, July 17th. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. Wells Fargo & Company increased their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday. Finally, JPMorgan Chase & Co. raised their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. One investment analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average target price of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.